Bristol Myers Squibb (BMY) Inventory Average (2009 - 2026)

Bristol Myers Squibb (BMY) has 17 years of Inventory Average data on file, last reported at $2.7 billion in Q1 2026.

• Inventory Average for Q1 2026 came in at $2.7 billion, up 4.27% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.7 billion (up 4.27% YoY), and the FY2025 annual result was $2.6 billion, up 0.54% from the prior year.
• Inventory Average was little changed at $2.7 billion in Q1 2026 per BMY's latest filing, from $2.7 billion in the prior quarter.
• Over five years, Inventory Average peaked at $3.2 billion in Q3 2024 and troughed at $2.1 billion in Q1 2022.
• A 5-year average of $2.6 billion and a median of $2.6 billion in 2025 frame the typical range for Inventory Average.
• The sharpest annual moves came in 2024 and 2025: Inventory Average jumped 33.52% in 2024, then decreased 14.26% in 2025.
• A 5-year view of Inventory Average shows it stood at $2.2 billion in 2022, then climbed by 15.52% to $2.5 billion in 2023, then increased by 15.52% to $2.9 billion in 2024, then fell by 7.49% to $2.7 billion in 2025, then decreased by 0.04% to $2.7 billion in 2026.
• Business Quant data shows BMY's Inventory Average at $2.7 billion in Q1 2026, $2.7 billion in Q4 2025, and $2.7 billion in Q3 2025.